GTX28093
antibody from GeneTex
Targeting: IGF2R
CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- GTX28093 - Provider product page
- Provider
- GeneTex
- Proper citation
- GeneTex Cat#GTX28093, RRID:AB_368984
- Product name
- IGF2R antibody [MEM-238]
- Antibody type
- Monoclonal
- Reactivity
- Human, Mouse, Simian
- Host
- Mouse
Submitted references Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease.
Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.
Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.
Koeberl DD, Austin S, Case LE, Smith EC, Buckley AF, Young SP, Bali D, Kishnani PS
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2014 May;28(5):2171-6
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2014 May;28(5):2171-6
Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.
Li S, Sun B, Nilsson MI, Bird A, Tarnopolsky MA, Thurberg BL, Bali D, Koeberl DD
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2013 Jan;27(1):34-44
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2013 Jan;27(1):34-44
Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.
Koeberl DD, Luo X, Sun B, McVie-Wylie A, Dai J, Li S, Banugaria SG, Chen YT, Bali DS
Molecular genetics and metabolism 2011 Jun;103(2):107-12
Molecular genetics and metabolism 2011 Jun;103(2):107-12
No comments: Submit comment
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Fig. 1. Western Blotting analysis (non-reducing conditions) of CD222 in whole cell lysate of JURKAT human peripheral blood T cell leukemia cell line. Lane 1: immunostaining with anti-CD222 [MEM-238]Lane 2: immunostaining with Isotype mouse IgG1 control